3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
23
Prostatic Neoplasms
12
Colorectal Neoplasms
12
Lung Neoplasms
11
Neoplasms
9
Lymphoma
6
Hematologic Neoplasms
6
Uterine Cervical Neoplasms
5
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Triple Negative Breast Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Hematopoietic and Lymphatic System Neoplasm
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Papillomavirus Infections
3
Obesity-Related Malignant Neoplasm
3
Obesity
3
Motor Activity
3
Endometrial Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Carcinoma In Situ
3
Anatomic Stage I Breast Cancer AJCC v8
3
Vulvar Neoplasms
2
Testicular Neoplasms
2
Smoking Cessation
2
Skin Carcinoma
2
Rectal Neoplasms
2
Interventions
Bevacizumab
4
Cetuximab
3
palbociclib
2
encorafenib
2
tislelizumab
1
ribociclib
1
repotrectinib
1
olaparib
1
fludarabine
1
durvalumab
1
dostarlimab
1
atezolizumab
1
Tretinoin
1
Stem Cell Transplantation
1
Sirolimus
1
Ramucirumab
1
Radiotherapy
1
Paclitaxel
1
Oxaliplatin
1
Oviposition
1
Melphalan
1
Lutetium-177
1
Lutetium
1
Levoleucovorin
1
Leucovorin
1
Irinotecan
1
Injections
1
Immunotherapy
1
Imatinib Mesylate
1
Hyperthermic Intraperitoneal Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Methods
×
1 year
×
Clear all
No trials found.